Elias S. Sotirchos
Johns Hopkins University
H-index: 28
North America-United States
Top articles of Elias S. Sotirchos
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A Noncanonical CD56dimCD16dim/− NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases | The Journal of Immunology | Soumya S Yandamuri Beata Filipek Nikhil Lele Inessa Cohen Jeffrey L Bennett | 2024/3/1 |
Rituximab for Multiple Sclerosis: Hiding in Plain Sight | Neurology | Annette Langer-Gould Elias S Sotirchos Dennis Bourdette | 2024/1/23 |
Validation Process of NMOSDCopilotTM, a Software as a Medical Device (SaMD) for Patients Living with Neuromyelitis Optica Spectrum Disorder (P10-14.001) | Michael Levy Elias Sotirchos Loic Carment Clarissa Gorin Lissandra Klaeyle | 2024/4/14 | |
Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease | medRxiv | Dimitrios C Ladakis Kimystian L Harrison Matthew D Smith Krista Solem Sachin Gadani | 2024/1/21 |
Validation of the international MOGAD panel proposed criteria: a single-centre US study | Journal of Neurology, Neurosurgery & Psychiatry | Angeliki G Filippatou Yana Said Haiwen Chen Eleni S Vasileiou Gelareh Ahmadi | 2024/4/3 |
A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis | Multiple Sclerosis Journal | Lynn Daboul Carly M O’Donnell Moein Amin Paulo Rodrigues John Derbyshire | 2024/1 |
Longitudinal evaluation of serum MOG-IgG titers in MOGAD after initiation of maintenance immunoglobulin: A case series | Multiple Sclerosis Journal | Shuvro Roy Eleni Vasileiou Paula Barreras Gelareh Ahmadi Haiwen Chen | 2024/4 |
Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy | Neurology: Neuroimmunology & Neuroinflammation | Nanthaya Tisavipat Hadas Stiebel-Kalish Dahlia Palevski Omer Y Bialer Heather E Moss | 2024/3/28 |
Reader Response: Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination | Elias S Sotirchos | 2023/9/8 | |
Author response to Drs. Golan & Miller | Elias S Sotirchos P Bhargava PA Calabresi | 2023/6/11 | |
Neurology Publish Ahead of Print | Yu-Chien Wu | 2023 | |
Effects of ibudilast on retinal atrophy in progressive multiple sclerosis subtypes: post hoc analyses of the SPRINT-MS trial | Neurology | Henrik Ehrhardt Jeffrey Lambe Hussein Moussa Eleni S Vasileiou Grigorios Kalaitzidis | 2023/9/5 |
Associations of sNfL with clinico‐radiological measures in a large MS population | Annals of Clinical and Translational Neurology | Elias S Sotirchos Kathryn C Fitzgerald Carol M Singh Matthew D Smith Maria Reyes‐Mantilla | 2023/1 |
Visual pathway involvement in NMDA receptor encephalitis: a clinical, optical coherence tomography, and 18-Fluorodeoxyglucose PET/CT approach | Journal of Neuro-Ophthalmology | Grigorios Kalaitzidis Angeliki Filippatou Nicholas Fioravante Alissa Rothman Elias S Sotirchos | 2023/6/1 |
Re: Vitamin D and MS: Not all is hunky dory | Elias S Sotirchos Pavan Bhargava Peter A Calabresi | 2023/8/10 | |
Trans‐Synaptic Degeneration Following Acute Optic Neuritis in Multiple Sclerosis | Annals of neurology | Olwen C Murphy Elias S Sotirchos Grigorios Kalaitzidis Elena Vasileiou Henrik Ehrhardt | 2023/1 |
Visual outcomes following plasma exchange for optic neuritis: an international multicenter retrospective analysis of 395 optic neuritis attacks | American Journal of Ophthalmology | John J Chen Eoin P Flanagan Sean J Pittock Nicole Caroline Stern Nanthaya Tisavipat | 2023/8/1 |
Vitreomacular Interface Abnormalities in Multiple Sclerosis; A Novel Signature of Disability (P10-3.013) | Hussein Moussa Grigorios Kalaitzidis Henrik Ehrhardt Olwen Murphy Eleni Vasileiou | 2023/4/25 | |
Re: Vitamin-D supplementation: Is the MS community studying too high a dose? | Elias S Sotirchos Peter A Calabresi | 2023/3/31 | |
The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives | Neurotherapeutics | Marjan Gharagozloo Danny Galleguillos Larissa Jank Elias S Sotirchos Matthew D Smith | 2023/7 |
